These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 515498)

  • 1. Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans.
    Shepherd AM; Ludden TM; Haegele KD; Talseth T; McNay JL
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):129-44. PubMed ID: 515498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference in assays for hydralazine in humans by a major plasma metabolite, hydralazine pyruvic acid hydrazone.
    Reece PA; Stanley PE; Zacest R
    J Pharm Sci; 1978 Aug; 67(8):1150-3. PubMed ID: 27629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of hydralazine pyruvic acid hydrazone and its correlation with "apparent" hydralazine.
    Haegele KD; Talseth T; Skrdlant HB; Shepherd AM; Huff SL
    Arzneimittelforschung; 1981; 31(2):357-62. PubMed ID: 7194654
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone.
    Talseth T; Haegele KD; McNay JL; Skrdlant HB; Clementi WA; Shepherd AM
    J Pharmacol Exp Ther; 1979 Dec; 211(3):509-13. PubMed ID: 512915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats.
    Ogiso T; Iwaki M; Ohtsuki N
    J Pharmacol Exp Ther; 1985 May; 233(2):485-90. PubMed ID: 3999031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous generation of hydralazine from labile hydralazine hydrazones.
    Clementi WA; McNay JL; Talseth T; Haegele KD; Ludden TM; Musgrave GE
    J Pharmacol Exp Ther; 1982 Jul; 222(1):159-65. PubMed ID: 7086698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man.
    Reece PA; Cozamanis I; Zacest R
    J Chromatogr; 1980 Mar; 181(3-4):427-40. PubMed ID: 7391156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers.
    Reece PA; Stafford I; Prager RH; Walker GJ; Zacest R
    J Pharm Sci; 1985 Feb; 74(2):193-6. PubMed ID: 3989691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype.
    Shen DD; Hosler JP; Schroder RL; Azarnoff DL
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):53-68. PubMed ID: 7381691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine kinetics after single and repeated oral doses.
    Shepherd AM; Ludden TM; McNay JL; Lin MS
    Clin Pharmacol Ther; 1980 Dec; 28(6):804-11. PubMed ID: 7438695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive effect of the hydralazine--acetone hydrazone in conscious rabbits: evidence for its back-conversion to hydralazine in vivo.
    Talseth T; McNay JL; Haegele KD
    J Cardiovasc Pharmacol; 1982; 4(3):370-4. PubMed ID: 6177931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine kinetics in hypertensive patients after intravenous administration.
    Ludden TM; Shepherd AM; McNay JL; Lin MS
    Clin Pharmacol Ther; 1980 Dec; 28(6):736-42. PubMed ID: 7438689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of food on the bioavailability of "real" and "apparent" hydralazine from conventional and slow-release preparations.
    Liedholm H; Wåhlin-Boll E; Hanson A; Melander A
    Drug Nutr Interact; 1982; 1(4):293-302. PubMed ID: 6926836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous dose on hydralazine kinetics after administration.
    Ludden TM; Shepherd AM; McNay JL; Lin MS
    Clin Pharmacol Ther; 1983 Aug; 34(2):148-52. PubMed ID: 6872407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro kinetic studies of the reaction of hydralazine and its acetone hydrazone with pyruvic acid.
    Iwaki M; Ogiso T; Ito Y
    J Pharm Sci; 1988 Mar; 77(3):280-3. PubMed ID: 3373434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine.
    Haegele KD; Skrdlant HB; Talseth T; McNay JL; Shepherd AM; Clementi WA
    J Chromatogr; 1980 Jan; 187(1):171-9. PubMed ID: 7358814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-pressure liquid chromatographic assay for hydralazine in human plasma.
    Ludden TM; Goggin LK; McNay JL; Haegele KD; Shepherd AM
    J Pharm Sci; 1979 Nov; 68(11):1423-5. PubMed ID: 512893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food on blood hydralazine levels and response in hypertension.
    Shepherd AM; Irvine NA; Ludden TM
    Clin Pharmacol Ther; 1984 Jul; 36(1):14-8. PubMed ID: 6734044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.
    Rashid JR; Kofi-Tsepko ; Juma FD
    East Afr Med J; 1992 Jul; 69(7):406-8. PubMed ID: 1396201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and biotransformation of hydralazine acetone hydrazone, a metabolite of hydralazine, in the rat.
    Iwaki M; Ogiso T; Ito Y
    J Pharm Sci; 1989 Oct; 78(10):867-73. PubMed ID: 2600796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.